47
OrbiMed closes $1.92B private equity fund X at 131 investors
Fund raise update · Private equity / buyout · Closed · Offering $1.92B · Sold $1.92B · NEW YORK, NY · filed 2026-10-16
3(c)(7) — qualified purchasers
Relevant to: Fund administrator, Fund audit & tax, Fund-formation counsel, Compliance consultant / RIA registration. Lead card pending.
| Mona Ashiya | Member of OrbiMed Advisors |
| Geoffrey C. Hsu | Member of OrbiMed Advisors |
| Matthew S. Rizzo | Member of OrbiMed Advisors |
| Carl L. Gordon | Member of OrbiMed Advisors |
| N/A OrbiMed Advisors LLC | "Managing Member of the GPLLC (""OrbiMed Advisors"")" |
| C. Scotland Stevens | Member of OrbiMed Advisors |
| David P. Bonita | Member of OrbiMed Advisors |
| Sven H. Borho | Member of OrbiMed Advisors |
| N/A OrbiMed Capital GP X, LP | "General Partner of the Issuer (the ""GPLP"")" |
| N/A OrbiMed Capital GP X LLC | "General Partner of the GPLP (the ""GPLLC"")" |
| Peter A. Thompson | Member of OrbiMed Advisors |
| W. Carter Neild | Member of OrbiMed Advisors |
Signed by W. Carter Neild, Member of OrbiMed Advisors.
Placement agents / sales compensation: UBS Switzerland AG; UBS Financial Services Inc.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.